Article
Gene editing enables rapid engineering of complex antibiotic assembly lines.
Nature communications - 25 Nov 2021
Thong Wei Li, Zhang Yingxin, Zhuo Ying, Robins Katherine J, Fyans Joanna K, Herbert Abigail J, Law Brian J C, Micklefield Jason
Abstract excerpt
Re-engineering biosynthetic assembly lines, including nonribosomal peptide synthetases (NRPS) and related megasynthase enzymes, is a powerful route to new antibiotics and other bioactive natural products that are too complex for chemical synthesis. However, engineering megasynthases is very challenging using current methods. Here, we describe how CRISPR-Cas9 gene editing can be exploited to rapidly engineer one...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
